Gland Pharma launches of the first non-frozen ready-to-use Bivalirudin
Bivalirudin RTU Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.